Research news
Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.
Researchers have identified small molecules secreted by the skin that are maybe responsible for a unique scent in people with Parkinson's.
Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.
A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.